Avantax Planning Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-322	Closed	-$2K	–	1377
2018 Q3	$2K	Buy	+322	New	+$2K	﹤0.01%	1392
2018 Q2	–	Sell	-422	Closed	-$3K	–	1721
2018 Q1	$3K	Buy	+422	New	+$3K	﹤0.01%	1558